Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Transplantation

Free Subscription 15.12.2025 1 Ann Surg 1 Clin Res Hepatol Gastroenterol 2 Clin Transplant 1 Dig Dis Sci 1 Gastroenterol Hepatol 1 Gut 1 J Hepatol 2 PLoS One 1 Transpl Int 3 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. KUNJU RD, Titus Varghese C, Nair K, Mallick S, et al
   Intermittent Inflow Occlusion in Robotic Right Donor Hepatectomy: A Randomized Controlled Trial.
   Ann Surg. 2026;283:65-71.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

2. LEPOUR M, Delorme A, Goffaux A, Trefois P, et al
   Low muscle density and Five Times Sit-to-Stand Test predict poor outcome in liver transplant candidates.
   Clin Res Hepatol Gastroenterol. 2025 Dec 10:102743.
   PubMed         Abstract available
   
   

   
   Clin Transplant

3. FOZOUNI L, Cullaro G, Lazar A, Lai JC, et al
   Neighborhood Deprivation Linked to Medication Level Variability in Liver Transplant Recipients.
   Clin Transplant. 2025;39:e70412.
   PubMed         Abstract available
   
   
4. LEE BT, Dodge JL, Voora S, Ahearn A, et al
   Comparison of Kidney Allograft Outcomes in Simultaneous Liver-Kidney Versus Kidney After Liver Transplantation Since the Safety Net Era.
   Clin Transplant. 2025;39:e70407.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

5. ZHANG J, Ren Y
   Lean MASLD Cirrhosis and Mortality: Considerations for Liver Transplant Candidate Evaluation.
   Dig Dis Sci. 2025 Dec 11. doi: 10.1007/s10620-025-09601.
   PubMed        
   
   

   
   Gastroenterol Hepatol

6. AZKUE IJG, Ferro JS, Iranzo ST, Benito VV, et al
   LIVER TRANSPLANTATION DUE TO HEPATOCELLULAR ADENOMA RUPTURE ASSOCIATED WITH ANABOLIC ANDROGENIC STEROID ABUSE.
   Gastroenterol Hepatol. 2025 Dec 5:502636. doi: 10.1016/j.gastrohep.2025.502636.
   PubMed        
   
   

   
   Gut

7. LUO J, Hu M, Feng T, Zhang L, et al
   Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies.
   Gut. 2025;75:131-146.
   PubMed         Abstract available
   
   

   
   J Hepatol

8. LI H, Zhao R, Zheng S, Xu X, et al
   Recurrence pattern for HBV-related HCC after liver transplantation in the antiviral era.
   J Hepatol. 2025 Dec 10:S0168-8278(25)02716-3. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   

   
   PLoS One

9. ALQAHTANI SA, AlMuhaidib S, Raptis DA, Al-Hamoudi WK, et al
   Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.
   PLoS One. 2025;20:e0338438.
   PubMed         Abstract available
   
   
10. LOPEZ-DIAZ G, Sanchez-Lorencio MI, Inarrairaegui M, Gonzalez-Dieguez ML, et al
    Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial.
    PLoS One. 2025;20:e0326442.
    PubMed         Abstract available
    
    

    
    Transpl Int

11. PROSPERI E, Prosperi E, Serenari M, Bonatti C, et al
    Evaluating Post-Transplant Outcomes in Elderly Liver Recipients Over 70: A Propensity-Score Matching Analysis.
    Transpl Int. 2025;38:15429.
    PubMed         Abstract available
    
    

    
    Transplant Proc

12. LI C, Sun Y, Din J, Cheng P, et al
    Predictive Value of Preoperative Serum Substance P Levels for Post-Transplant Recurrence in Patients With Hepatocellular Carcinoma.
    Transplant Proc. 2025 Nov 18:S0041-1345(25)00535.
    PubMed         Abstract available
    
    
13. COTE MP, Atthota S, Cataldo J, MacDonald A, et al
    Feasibility, Acceptability, and Satisfaction of a Lifestyle Intervention for Post-Transplant Weight Loss.
    Transplant Proc. 2025;57:1999-2009.
    PubMed         Abstract available
    
    
14. ABE T, Furukawa M, Matsuno N, Sakamoto S, et al
    Optimization of Oxygen Supply Conditions for Hypothermic Oxygenated Machine Perfusion.
    Transplant Proc. 2025;57:1869-1872.
    PubMed         Abstract available
    
    

    
    Transplantation

15. LIU A, Elhawary A, Cole K, Watt KD, et al
    Cumulative Risk Assessment for De Novo and Recurrent Nonliver Cancer After Liver Transplantation Based on Pretransplant Cancer Experience.
    Transplantation. 2025 Dec 5. doi: 10.1097/TP.0000000000005576.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.